Literature DB >> 16739218

Routine immunophenotyping in acute leukemia: Role in lineage assignment and reassignment.

Misbah Qadir1, Maurice Barcos, Carleton C Stewart, Sheila N J Sait, Laurie A Ford, Maria R Baer.   

Abstract

Diagnostic evaluation of acute leukemia at Roswell Park Cancer Institute has routinely included immunophenotyping by multiparameter flow cytometry. In a retrospective analysis of 646 cases, morphology and cytochemistry established lineage in 612, but not in 34 (5%), of which 26, 5, and 3 were myeloid, undifferentiated, and lymphoid, respectively, based on immunophenotyping. In addition, immunophenotyping changed the lineage assigned based on morphology and cytochemistry in 11 cases (2%); 8 changed from lymphoid to myeloid, and 3 from myeloid to lymphoid. The data support routine inclusion of at least limited immunophenotyping in the diagnostic evaluation of acute leukemia. Copyright 2006 International Society for Analytical Cytology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16739218     DOI: 10.1002/cyto.b.20112

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  2 in total

1.  Flow cytometry immunophenotyping evaluation in acute lymphoblastic leukemia: correlation to factors affecting clinic outcome.

Authors:  Gabriela Vasconcelos de Andrade Alves; Andrea Luciana Araújo da Cunha Fernandes; Juliana Mendonça Freire; Aldair de Souza Paiva; Roberto Chaves de Vasconcelos; Valéria Soraya de Farias Sales; Telma Maria de Araújo Moura Lemos; Erica Aires Gil; Flávio Henrique Miranda de Araújo Freire; Dany Geraldo Kramer Cavalcanti e Silva; James Farley Rafael Maciel; Irian Guedes Farkatt; Geraldo Barroso Cavalcanti Júnior
Journal:  J Clin Lab Anal       Date:  2012-11       Impact factor: 2.352

2.  Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 Protocol.

Authors:  Eddy Supriyadi; Anjo J P Veerman; Ignatius Purwanto; Peter M Vd Ven; Jacqueline Cloos
Journal:  J Oncol       Date:  2012-11-26       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.